A personal story by German writer Norman Ohler has reignited the debate on psychedelics and dementia. During an Oxford Union meeting, he recounted how his mother, who suffers from Alzheimer's, showed temporary improvement according to the family after being administered a microdose of LSD. The story aligns with a growing stream of scientific research into the possible role of psychedelics in neurodegenerative disorders.
Noticeable change after microdose
According to Ohler, on the day of her first microdose, his mother spoke more easily than before and was able to read a newspaper headline aloud again for the first time in over a year. The treatment was later discontinued, not due to health problems, but because LSD is banned in Germany and the care facility did not allow any exceptions.
Although it concerns a personal experience, the story has received a lot of international attention.
More research into psychedelics
Other organizations are also investigating the possible effects of LSD on brain disorders. For example, the Beckley Foundation previously described a similar case in which a 97-year-old woman with advanced Alzheimer's showed temporary improvement after treatment with a low dose of LSD.
Additionally, along the University of Basel a controlled study investigating whether microdoses of LSD are safe and could potentially contribute to the preservation of cognitive functions.
Why researchers are interested
Scientists suspect that low doses of LSD can influence processes in the brain involved in neuroplasticity: the brain's ability to form new connections. Research is also being conducted into whether the substance affects inflammatory processes and proteins that play a role in the development of Alzheimer's.
To date, however, most results are derived from laboratory research or individual cases. There is no convincing clinical evidence yet that microdosing LSD can treat or slow dementia.
cautious optimism
Experts emphasize that people should not experiment with LSD as a treatment for dementia on their own. The current scientific evidence is insufficient for this, and the risks are not fully known.
However, the research shows that psychedelics are being investigated increasingly seriously as potential medications for neurological and psychiatric disorders. In the coming years, larger clinical studies must determine whether LSD can actually play a role in the treatment of dementia.
Ready to see how Snowflake works?
Norman Ohler's story has once again drawn attention to the potential therapeutic applications of LSD. Although the initial signs are interesting, the research is still in an early stage. For the time being, microdosing for dementia remains an area of experimental research and not a proven treatment.
